1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
CYP3A7*1C allele : linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Johnson, Nichola ; Augustinsson, Annelie LU ; Brenner, Hermann LU ; Burwinkel, Barbara ; Hall, Per LU ; Olsson, Håkan LU
and Fletcher, Olivia
(2021)
In British Journal of Cancer
124(4).
p.842-854
Mark
- 2020
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
- 2018
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
- 2017
- MiR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome
- 2016
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus